[2] Patrizia D., Carbone A., Barraja P., Kelter G., Fiebig H.H., Cirrincione G.,
Synthesis and Antitumor Activity of 2,5-bis(3′-indolyl)-furans and 3,5-bis(3′-indolyl)-Isoxazoles, Nortopsentin Analogues,
Bioorg. Med. Chem.,
18(12):4524-4529 (2010).
[3] Talley J.J., Brown D.L., Carter J.S., Graneto M.J., Koboldt C.M., Masferrer J.L., Perkins W.E., Rogers R.S., Shaffer A.F., Zhang Y.Y., Zweifel B.S., Seibert K.,
4-[5-Methyl-3-Phenylisoxazol-4-yl] -Benzene Sulfonamide, Valdecoxib: A Potent and Selective Inhibitor of COX-2,
J. Med. Chem.,
43(5): 775-777 (2000).
[7] Kamal A., Bharathi E.V., Reddy J.S., Janaki M., Ramaiah D., Reddy M.K., Viswanath A., Reddy T. L., Shaik T.B., Pushpavalli S.N.C.V.L., Bhadra M.P.,
Synthesis and Biological Evaluation of 3,5-Diaryl Isoxazoline/Isoxazole Linked 2,3-Dihydroquinazolinone Hybrids as Anticancer Agents,
Eur.
J. Med. Chem.,
46(2):691-703 (2011).
[8] Santos M.M.M., Faria N., Iley J., Coles S.J., Hursthouse M.B., Martins M., Moreira R.,
Reaction of Naphthoquinones with Substituted Nitromethanes. Facile Synthesis and Antifungal Activity of Naphtho[2,3-d]Isoxazole-4,9-Diones,
Bioorg. Med. Chem. Lett.,
20(1):193-195 (2010).
[14] Zhang X.H., Wang L.Y., Zhan Y.H., Fu Y.L., Zhaia G.H., Wenc Z.Y.,
Synthesis and Structural Studies of
4-[(5-Methoxy-1h-Indole-3-yl)-Methylene]-3-Methyl-Isoxazole-5-One by X-Ray Crystallography, NMR Spectroscopy, and DFT Calculations,
J. Mol.
Struct.,
994(1-3):371-378 (2011).
[18] Liu Z., Han B., Liu Q., Zhang W., Yang L., Liu Z.–L., Yu W.,
Selective Reduction of The Exocyclic Double Bond of Isoxazolones and Pyrazolones by Hantzsch 1,4-Dihydropyridine,
Synlett, 10:1579-1580 (2005).